Description: InDex Pharmaceuticals Holding AB (publ) engages in the research and development of pharmaceuticals for immunological diseases. The company was founded in 2000 and is headquartered in Solna, Sweden.
Home Page: www.indexpharma.com
Berzelius väg 13
Solna,
171 65
Sweden
Phone:
46 8 12 20 38 50
Officers
| Name | Title |
|---|---|
| Mr. Johan Gileus | Deputy CEO & Chief Financial Officer |
| Ms. Jenny Sundqvist | Chief Executive Officer |
| Dr. Charlotte Admyre | Chief Scientific Officer |
| Ms. Margareth Jorvid | Head of Regulatory Affairs |
| Ms. Eva Arlander | Chief Development Officer |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.462 |
| Price-to-Sales TTM: | 0.1566 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 4 |